| CXSB1900006 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2019-03-20 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2019-03-19 | view |
| CXSB1900020 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2019-08-28 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2019-08-27 | view |
| CXSB1900025 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2019-11-08 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2019-11-07 | view |
| CXSB2000008 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2020-04-22 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2020-04-21 | view |
| CXSB2000014 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2020-05-19 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2020-05-18 | view |
| CXSB2000015 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2020-05-19 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2020-05-18 | view |
| CXSB2000018 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2020-06-13 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2020-06-12 | view |
| CXSB2000024 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2020-06-30 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2020-06-29 | view |
| CXSB2000052 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2020-09-12 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2020-09-30 | view |
| CXSB2100007 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2021-01-19 | 百济神州（上海）生物科技有限公司 | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | In Review | 2021-01-19 | view |
| CXSB2101013 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2021-05-19 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSB2101058 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-11-10 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSB2101061 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2021-11-23 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSB2101064 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2021-12-08 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSB2101065 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-12-16 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSB2200007 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2022-01-21 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSB2200046 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | Supplementary Application | 2022-05-24 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSB2200049 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | Supplementary Application | 2022-06-08 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSB2200053 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | Supplementary Application | 2022-06-21 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSB2200055 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | Supplementary Application | 2022-06-24 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
